NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30183% above fair value
$5.00+0.18 (+3.74%)
Close on Nov 19, 2026Market cap $60.78MP/E –Yield –
NutriBand gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
NutriBand's gross profit for the twelve months ending Jul 31, 2026 was $536.12K, down 39.5% year over year. For fiscal 2026 it was $566.31K, down 23.8% from the year before. The highest annual figure on record is $862.11K in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $566.31K | -23.8% |
| FY2025 | Jan 31, 2025 | $743.32K | -13.8% |
| FY2024 | Jan 31, 2024 | $862.11K | +14.9% |
| FY2023 | Jan 31, 2023 | $750.40K | +35.4% |
| FY2022 | Jan 31, 2022 | $554.31K | +75.3% |
| FY2021 | Jan 31, 2021 | $316.23K | – |
| FY2020 | Jan 31, 2020 | -$429.74K | – |
| FY2019 | Jan 31, 2019 | -$43.02K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $181.87K | +15.9% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $196.80K | -21.9% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $88.94K | -68.9% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $68.51K | -64.1% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $156.88K | +54.5% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $251.98K | +52.9% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $285.94K | +57.8% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $191.03K | +19.6% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $101.56K | -66.1% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $164.79K | -25.9% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $181.23K | +40.0% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $159.72K | -40.4% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $299.67K | +97.4% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $222.28K | +10.9% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $129.48K | -46.4% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $268.19K | +12.7% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $151.80K | +7.4% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $200.49K | +23.0% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $241.35K | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $237.88K | +435.5% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $141.36K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $163.03K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$32.49K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $44.43K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$106.65K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$23.56K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$43.05K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$5.20K | – |
See a number that looks wrong?